These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22632378)

  • 1. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.
    Roxburgh CS; McTaggart F; Balsitis M; Diament RH
    Colorectal Dis; 2013 Jan; 15(1):34-41. PubMed ID: 22632378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
    Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
    Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
    Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
    Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.
    Steele RJ; McClements PL; Libby G; Carey FA; Fraser CG
    Colorectal Dis; 2014 Jan; 16(1):28-32. PubMed ID: 24034143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms do not predict colorectal cancer in an FOB screened population.
    Saldanha JD; Moug SJ; Linton K; Diament RH
    Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
    Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
    Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre.
    Mackay C; Ramsay G; Rafferty A; Loudon M
    J Eval Clin Pract; 2014 Feb; 20(1):7-11. PubMed ID: 23890078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
    Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
    Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study.
    Goodyear SJ; Stallard N; Gaunt A; Parker R; Williams N; Wong L
    Br J Surg; 2008 Sep; 95(9):1172-9. PubMed ID: 18690636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
    Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
    Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Goodyear SJ; Leung E; Menon A; Pedamallu S; Williams N; Wong LS
    Gut; 2008 Feb; 57(2):218-22. PubMed ID: 18048571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urgency of referral and its impact on outcome in patients with colorectal cancer.
    Ramsay G; MacKay C; Nanthakumaran S; Craig WL; McAdam TK; Loudon MA
    Colorectal Dis; 2012 Jul; 14(7):e375-7. PubMed ID: 22284530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of the '2-week wait' referral service for colorectal cancer.
    Leung E; Grainger J; Bandla N; Wong L
    Int J Clin Pract; 2010 Nov; 64(12):1671-4. PubMed ID: 20946272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the location of colorectal carcinoma differ between screened and unscreened populations?
    Mackay CD; Ramsay G; Rafferty A; Loudon MA
    Colorectal Dis; 2012 Oct; 14(10):e689-91. PubMed ID: 22726268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.
    Ellul P; Fogden E; Simpson CL; Nickerson CL; McKaig BC; Swarbrick ET; Veitch AM
    Colorectal Dis; 2010 May; 12(5):420-2. PubMed ID: 19843116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland.
    Mansouri D; McMillan DC; Crearie C; Morrison DS; Crighton EM; Horgan PG
    Br J Cancer; 2015 Jul; 113(3):556-61. PubMed ID: 26158422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.